OLPX
Get informed when a big investor buys or sells
+ FollowUndervalued by 92.6% based on the discounted cash flow analysis.
| Market cap | $1.37 Billion |
|---|---|
| Enterprise Value | $1.40 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 1.87 |
| Outstanding Shares | 669,942,446 |
| P/E Ratio | -91.09 |
|---|---|
| PEG | 7.36 |
| Price to Sales | - |
| Price to Book Ratio | 2.03 |
| Enterprise Value to Revenue | 3.29 |
| Enterprise Value to EBIT | 431.26 |
| Enterprise Value to Net Income | -94 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.4 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4460▼ 45.21% |
|---|---|
| Total Calls | 328,700▲ 946.82% |
| Total Puts | 146,600▲ 419.86% |
Holdings and activity of institutional investors.
| Ownership % | 89.21%▲ 0.27% |
|---|---|
| Total Invested | $1.21B▲ 51.80% |
| Investors Holding | 159▲ 20.00% |
No data
Although advisory, it directly influences the development and analysis of tax legislation, which determines corporate tax burdens, capital investment credits, and overall fiscal policy significantly impacting Olaplex's financial performance.
Directly controls tax policy and trade (including tariffs), which profoundly impacts corporate profitability, supply chain costs for raw materials, and the overall valuation of a manufacturing company like Olaplex.
Regulates labor laws, which directly impact manufacturing costs, and potentially the FDA, which oversees consumer chemical products (like cosmetics, which Olaplex is known for), impacting product safety and market entry.
Its oversight of intellectual property law is crucial for a chemical company relying on proprietary formulations, and antitrust review can impact potential M&A activities or market competition directly affecting Olaplex.
Directly regulates the EPA, which imposes significant environmental and chemical safety regulations (e.g., TSCA) on all chemical manufacturers, including Olaplex. Committee members would have direct insight into potential regulatory changes impacting operational costs and product formulations.